Imunon (IMNN) News Today → New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad) Free IMNN Stock Alerts $1.12 -0.01 (-0.88%) (As of 04/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineIMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101finance.yahoo.com - April 18 at 9:47 AMIMUNON's IND Application Cleared to Begin Human Testing of IMNN-101globenewswire.com - April 18 at 8:30 AMImunon, Inc.: IMUNON Reports Compliance with Nasdaq Listing Requirementsfinanznachrichten.de - April 11 at 9:16 AMIMUNON Reports Compliance with Nasdaq Listing Requirementsglobenewswire.com - April 11 at 8:00 AMImunon, Inc. (IMNN) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 30 at 7:14 PMIMUNON Reports 2023 Financial Results and Provides Business Updateglobenewswire.com - March 28 at 8:00 AMIMUNON Receives $1.3 Million from Sale of its New Jersey Net Operating Lossesglobenewswire.com - March 25 at 8:30 AMIMUNON to Hold 2023 Financial Results and Business Update Conference Call on Thursday, March 28, 2024globenewswire.com - March 21 at 5:00 PMImunon, Inc.: IMUNON Announces Leadership Changefinanznachrichten.de - March 15 at 7:51 AMIMUNON CEO steps down, Executive Chairman takes helmuk.investing.com - March 14 at 7:36 PMAnalysts Offer Insights on Healthcare Companies: Imunon (IMNN) and CalciMedica (CALC)markets.businessinsider.com - March 13 at 7:34 PMIMUNON Files IND Application to Begin Human Testing of IMNN-101globenewswire.com - March 13 at 8:00 AMIMUNON Announces Leadership Changeglobenewswire.com - March 12 at 5:00 PMIMUNON reports promising vaccine study resultsuk.investing.com - March 2 at 8:58 AMIndependent Lab Confirms Immunogenicity and Protection with IMUNON's IMNN-101 in a Live Virus Challenge Against SARS-CoV-2 Variant XBB.1.5globenewswire.com - February 29 at 8:30 AMWhy Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Sessionbenzinga.com - February 28 at 2:20 PMIMUNON continues subject enrolment in Phase I/II ovarian cancer trialmsn.com - February 28 at 2:20 PMMemorial Sloan Kettering Cancer Center Now Enrolling Patients in Phase 1/2 Clinical Trial of IMUNON’s IMNN-001 in Combination with Bevacizumab in Advanced Ovarian Cancerfinance.yahoo.com - February 27 at 9:35 AMMemorial Sloan Kettering Cancer Center Now Enrolling Patients in Phase 1/2 Clinical Trial of IMUNON's IMNN-001 in Combination with Bevacizumab in Advanced Ovarian Cancerglobenewswire.com - February 27 at 8:30 AMIMNN-101 Preclinical Data in SARS CoV-2 Published in Peer-Reviewed Journal Vaccineglobenewswire.com - February 22 at 8:00 AMBicycle Therapeutics Ltd. ADRwsj.com - February 16 at 8:21 AMIMUNON Appoints Dr. Sebastien Hazard as Chief Medical Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)finance.yahoo.com - December 11 at 10:15 AMImunon, Inc. (NASDAQ:IMNN) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 20 at 7:29 PMIMNN: Promising Interim PFS and OS Data for IMNN-001 in OVATION 2 Trial… - MSNmsn.com - November 17 at 6:43 PMIMNN: Promising Interim PFS and OS Data for IMNN-001 in OVATION 2 Trial…finance.yahoo.com - November 17 at 6:43 PMImunon, Inc.: IMUNON Reports Third Quarter 2023 Financial Results and Provides a Business Updatefinanznachrichten.de - November 14 at 3:11 PMIMUNON's VP of R&D to Present at the Vaccines Summit-2023tmcnet.com - November 14 at 3:11 PMImunon GAAP EPS of -$0.37 beats by $0.29msn.com - November 14 at 10:11 AMImunon: Q3 Earnings Insightsbenzinga.com - November 14 at 10:11 AMIMUNON Reports Third Quarter 2023 Financial Results and Provides a Business Updatefinance.yahoo.com - November 14 at 10:11 AMIMUNON’s VP of R&D to Present at the Vaccines Summit-2023finance.yahoo.com - November 14 at 10:11 AMImunon Q3 Earnings Previewmsn.com - November 13 at 1:26 PMImunon's Earnings Outlookbenzinga.com - November 13 at 1:26 PMIMUNON to Hold Third Quarter 2023 Financial Results and Business Update Conference Call on Tuesday, November 14, 2023finance.yahoo.com - November 7 at 9:57 AMIMUNON’s Chief Science Officer to Present at the 3rd International Vaccines Congressfinance.yahoo.com - October 23 at 8:40 AMIMUNON treats first patient in ovarian cancer therapy trialmsn.com - October 19 at 6:50 PMIMUNON CEO Dr. Corinne Le Goff to Participate in a Panel Discussion on Pandemic Preparedness at the United Nationsfinance.yahoo.com - October 19 at 8:49 AMIMUNON Announces First Patient enrolled in Phase 1/2 Clinical Trial of IMNN-001 in Combination with bevacizumab in Advanced Ovarian Cancerfinance.yahoo.com - October 18 at 8:56 AMIMUNON Appoints Dr. Patrick Ott to its Scientific Advisory Boardfinance.yahoo.com - October 6 at 10:38 AMImunon Highlights Early Data From Lead Program In Ovarian Cancerbenzinga.com - September 28 at 1:34 PMIMUNON Reports Interim Progression-Free Survival and Overall Survival Data in Phase 1/2 OVATION 2 Study in Advanced Ovarian Cancerfinance.yahoo.com - September 28 at 1:34 PMIMUNON Releases Enterprise Video Highlighting the Company’s Mission, Vision, Values, Breakthroughs and Technologiesfinance.yahoo.com - September 26 at 8:56 AMIMNN: R&D Day Highlights Company Pipeline…finance.yahoo.com - September 18 at 12:48 PMImunon Inc.barrons.com - September 18 at 7:48 AMAnalysts Have Conflicting Sentiments on These Healthcare Companies: Imunon (IMNN) and Laboratory (LH)markets.businessinsider.com - September 15 at 1:23 PMIMUNON Reminds Investors of its Virtual R&D Day Tomorrow at 4:00 p.m. ETfinance.yahoo.com - September 13 at 6:57 PMIMUNON to Host Virtual R&D Day on September 14th Beginning at 4:00 p.m. ETfinance.yahoo.com - September 7 at 6:56 PMIMUNON to Participate in the H.C. Wainwright Global Investment Conferencefinance.yahoo.com - September 5 at 6:07 PMImunon Inc's Rocky Road Ahead: Unraveling the Factors Limiting Growthfinance.yahoo.com - August 25 at 6:33 PMIs Imunon (IMNN) Modestly Overvalued? A Comprehensive Valuation Analysisfinance.yahoo.com - August 25 at 6:33 PM Get Imunon News Delivered to You Automatically Sign up to receive the latest news and ratings for IMNN and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden’s $374B Giveaway Into This Sector (Ad)Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here Click here for the full story IMNN Media Mentions By Week IMNN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMNN News Sentiment▼0.490.53▲Average Medical News Sentiment IMNN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMNN Articles This Week▼21▲IMNN Articles Average Week Get Imunon News Delivered to You Automatically Sign up to receive the latest news and ratings for IMNN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: EDSA News Today JAN News Today AVTX News Today KPRX News Today MIRA News Today ORGS News Today BNTC News Today RDHL News Today COCP News Today TNXP News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMNN) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIThe “Perfect Storm” for GoldGold Safe ExchangeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceUrgent alert: open this for a huge profit potentialTimothy SykesHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imunon, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.